Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: J Mol Cell Cardiol. 2011 Apr 8;51(1):4–15. doi: 10.1016/j.yjmcc.2011.03.001

Table 1.

Morphometric analysis of cardiomyocytes

Cell treatment Area (μm2) Major axis (μm) Minor axis (μm) Major/minor
Ad.GFP 2123 ± 632 62 ± 11 40 ± 10 1.42 ± 0.32
Ad.RAF1 WT 3540 ± 1050 136 ± 35 33 ± 13 4.70 ± 1.98*
Ad.RAF1L613V 3821 ± 1000 140 ± 38 32 ± 13 4.98 ± 2.15*
Ad.GFP+ Ad.MEKDN 1982 ± 870 65 ± 15.34 43 ± 17.62 1.00 ± 0.41
Ad.RAF1 WT+ Ad.MEKDN 3780 ± 1100 142 ± 37.02 35 ± 11.43 4.50 ± 2.00*
Ad.RAF1 L613V+ Ad.MEKDN 3928 ± 1032 141 ± 40 34 ± 13.72 4.62 ± 2.15*
Ad.GFP+ Ad.ASKDN 1962 ± 670 54 ± 15 44 ± 13.56 1.00 ± 0.21
Ad.RAF1 WT+ Ad.ASKDN 3092 ± 890 142 ± 37.73 37 ± 9.2 4.60 ± 2.05*
Ad.RAF1 L613V+ Ad.ASKDN 3789 ± 980 136 ± 43.98 34 ± 13 4.90 ± 4.15*
Ad.GFP+ Ad.VIVIT 1937 ± 423 51 ± 02 41 ± 11 1.20 ± 0.01
Ad.RAF1 WT+ Ad.VIVIT 3370 ± 992 132 ± 41 34 ± 11.2 4.59 ± 1.88*
Ad.RAF1 L613V+ Ad.VIVIT 2003 ± 312 59 ± 13 39 ± 15 1.35 ± 0.12
Ad.GFP+ Ad.MEF2DN 1999 ± 356 49 ± 3 40 ± 8 1.01 ± 0
Ad.RAF1 WT+ Ad.MEF2DN 1890 ± 567 49 ± 02 39 ± 6.87 0.99 ± 0.2
Ad.RAF1 L613V+ Ad.MEF2DN 3800 ± 890 141 ± 33 29 ± 12 4.99 ± 1.68*

Values are means of SD of three independent experiments;

*

P≤ 0.01 versus GFP cells